Comparative safety and effectiveness of standard doses of apixaban versus dabigatran, rivaroxaban, and VKAs in non-valvular atrial fibrillation patients in France: the NAXOS study

被引：0
|
作者：
Danchin, N. [1 ]
Steg, P. G. [2 ]
Hanon, O. [3 ]
Mahe, I. [4 ]
Belhassen, M. [5 ]
Jacoud, F. [5 ]
Nolin, M. [5 ]
Ginoux, M. [5 ]
Dalon, F. [5 ]
Lefevre, C. [6 ]
Cotte, F. E. [6 ]
Gollety, S. [6 ]
Falissard, B. [7 ]
Van Ganse, E. [5 ]
机构：
[1] Hop Europeen Georges Pompidou, Cardiol, Paris, France
[2] Univ Paris Diderot, Bichat Hosp, FACT, INSERM,UMR1148, Paris, France
[3] Hosp Broca Paris, Geriatr Med, Paris, France
[4] Paris Diderot Univ, Hosp Louis Mourier, AP HP, Internal Med,INSERM,UMR 1140, Colombes, France
[5] Pharmacoepidemiol Lyon PELyon, Lyon, France
[6] Bristol Myers Squibb, Rueil Malmaison, France
[7] Ctr Res Epidemiol & Populat Hlth, INSERM, U1018, CESP, Paris, France
来源：
EUROPEAN HEART JOURNAL | 2019年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1255
引用
收藏
页码：711 / 711
页数：1
相关论文
共 50 条
  • [1] Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation
    Andersson, Niklas W.
    Svanstrom, Henrik
    Lund, Marie
    Pasternak, Bjorn
    Melbye, Mads
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 268 : 113 - 119
  • [2] Comparative Effectiveness of Dabigatran and Rivaroxaban versus Warfarin in Patients With Non-Valvular Atrial Fibrillation
    Bengtson, Lindsay
    Chen, Lin
    MacLehose, Richard
    Lutsey, Pamela
    Alonso, Alvaro
    [J]. CIRCULATION, 2014, 130
  • [3] Comparative effectiveness of warfarin, dabigatran, rivaroxaban and apixaban in non-valvular atrial fibrillation: A nationwide pharmacoepidemiological study
    Kjerpeseth, Lars J.
    Selmer, Randi
    Ariansen, Inger
    Karlstad, Oystein
    Ellekjaer, Hanne
    Skovlund, Eva
    [J]. PLOS ONE, 2019, 14 (08):
  • [4] Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation
    Norby, Faye L.
    Bengtson, Lindsay G. S.
    Lutsey, Pamela L.
    Chen, Lin Y.
    MacLehose, Richard F.
    Chamberlain, Alanna M.
    Rapson, Ian
    Alonso, Alvaro
    [J]. BMC CARDIOVASCULAR DISORDERS, 2017, 17
  • [5] Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation
    Faye L. Norby
    Lindsay G.S. Bengtson
    Pamela L. Lutsey
    Lin Y. Chen
    Richard F. MacLehose
    Alanna M. Chamberlain
    Ian Rapson
    Alvaro Alonso
    [J]. BMC Cardiovascular Disorders, 17
  • [6] Direct comparison of dabigatran, apixaban, rivaroxaban and edoxaban for effectiveness and safety among patients with non-valvular atrial fibrillation
    Choi, E. -K.
    Lee, S. R.
    Kwon, S.
    Han, K. D.
    Jung, J. H.
    Oh, S.
    Lip, G. Y. H.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 2986 - 2986
  • [7] Comparative effectiveness of dabigatran and rivaroxaban versus warfarin for the treatment of non-valvular atrial fibrillation
    Bengtson, Lindsay G. S.
    Lutsey, Pamela L.
    Chen, Lin Y.
    MacLehose, Richard F.
    Alonso, Alvaro
    [J]. JOURNAL OF CARDIOLOGY, 2017, 69 (5-6) : 868 - 876
  • [8] Effectiveness and safety of apixaban, dabigatran and warfarin compared to rivaroxaban in non-valvular atrial fibrillation; a Norwegian nationwide cohort study
    Rutherford, O. -C. W.
    Jonasson, C. J.
    Ghanima, W. G.
    Halvorsen, S. H.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 1846 - 1846
  • [9] EFFECTIVENESS AND SAFETY OF STANDARD AND REDUCED DOSES OF DABIGATRAN VERSUS RIVAROXABAN IN NON-VALVULAR ATRIAL FIBRILLATION: A COHORT STUDY IN THE SNDS FRENCH NATIONWIDE CLAIMS DATABASE
    Blin, P.
    Cottin, Y.
    Dureau-Pournin, C.
    Abouelfath, A.
    Lassalle, R.
    Benichou, J.
    de Pouvourville, G.
    Mismetti, P.
    Droz-Perroteau, C.
    Moore, N.
    [J]. VALUE IN HEALTH, 2018, 21 : S7 - S7
  • [10] Comparative safety and effectiveness of dabigatran vs. rivaroxaban and apixaban in patients with non-valvular atrial fibrillation: a retrospective study from a large healthcare system
    Villines, Todd C.
    Ahmad, Azhar
    Petrini, Michaela
    Tang, Wenbo
    Evans, Amber
    Rush, Toni
    Thompson, David
    Oh, Kelly
    Schwartzman, Eric
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2019, 5 (02) : 80 - 90
12345